Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
Where this comes from
- Record sourced from PubMed, PMID 33535239.
- Also identified by DOI 10.1093/infdis/jiaa637 and PMC identifier 7798939.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Developers of severe acute respiratory syndrome coronavirus 2 vaccines should consider some of the lessons from a "new" vaccine introduced in 1921, namely bacille Calmette-Guérin.
Medical subject headings
- BCG Vaccine
- COVID-19
- COVID-19 Vaccines
- SARS-CoV-2